← All companies
Relay Therapeutics, Inc.
RLAY - CIK 0001812364
Market cap$2.60 B
Rank#1914
SEC filings506
The table below shows Relay Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $84.02M | $124.29M | $143.74M | $151.79M | $280.12M | $447.65M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | $306.00K | $306.00K | $403.00K | $75.00M |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.